bpc-157 clinical trials latest and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded Multifunctionality and Possible Medical Application

Description

Choose 2mL (5mg/mL) if: You are starting retatrutide for the first time Your current dose is 5mg per week or lower You want maximum measurement accuracy You prefer straightforward math Choose 1mL (10mg/mL) if: Your dose is 6mg per week or higher You want smaller injection volumes You are comfortable with precise syringe measurements You have experience reconstituting peptides Some researchers start with 2mL during their initial escalation phase and switch to 1mL once they reach maintenance doses above 4mg

In summary, this effect may be the cause or a consequence of the beneficial effects of BPC 157 on related disturbances [1,2,3,4,5,6,7,8,9,10,11]

I would suggest that you need to read all of the studies before you reach a conclusion

Researchers study retatrutide in preclinical and clinical settings related to incretin and glucagon receptor signaling and downstream metabolic endpoints